What are the opening hours?

Monday 9am - 5am Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Alfa Cytology

Name: Alfa Cytology
Address: 500-B Wheeler Road, Hauppauge, NY, 11788, US
Telephone: +15164410170

Call Directions Website Contact the business

Alfa Cytology offers seamless services from target discovery to IND.

Our comprehensive drug discovery services and diverse technology platforms cater to various client needs.

11/03/2026

🧬 Assessing Merck and Moderna’s mRNA cancer vaccine

• On this week's “The Readout LOUD,” we discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.

💡 Cancer vaccines are emerging as a pillar of immuno-oncology — Alfa Oncology supports your vaccine program from design to evaluation.
👉 Learn more: https://www.alfaoncology.com

10/29/2026

🧬 Outpace ends an ovarian cancer trial; Incyte data impresses at ESMO

• Plus news about Genmab, Rumi, Prana and Fractyl.
• Outpace Bio ends cell therapy trial: The Seattle startup canned a Phase 1 ovarian cancer trial of its mesothelin autologous CAR-T, called OPB-101 .

💡 Ovarian cancer research demands clinically relevant models — Alfa Cytology offers dedicated ovarian cancer preclinical services.
👉 Learn more: https://www.alfacytology.com/ovarian-cancer

10/27/2026

🧬 BioNTech, DualityBio ponder next steps for HER2 ADC after 'modest' breast cancer results

• BioNTech and DualityBio are mulling what to do next with trastuzumab pamirtecan in certain breast cancer patients after the antibody-drug conjugate delivered a “statistically significant, yet modest” success in a Phase 3 trial.

💡 Duo-ADC redefines the ADC ceiling with dual-target engagement and dual-payload synergy — Alfa Cytology's ADC platform covers screening to IND.
👉 Learn more: https://www.alfacytology.com/duoadc/

10/22/2026

🧬 Bridging the Translational Gap in Pancreatic Cancer Through Biology-First Modeling

• In this GEN webinar, our expert speaker Josh Wheeler, MD, PhD, will discuss a biology-first, interpretable AI approach to understand patient tumor states and next-generation preclinical models that reproduce their biological complexity.

💡 Pancreatic cancer is among the hardest solid tumors to treat — Alfa Cytology's pancreatic cancer models help you make early decisions count.
👉 Learn more: https://pancreatic-cancer.alfacytology.com/

10/20/2026

🧬 FDA Approves Jaypirca (Pirtobrutinib) for Two Rare Blood Cancers

• The US Food and Drug Administration (FDA) has approved pirtobrutinib for adults with previously untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) with no known 17p deletion.

💡 Leukemia drug development needs robust in vitro and in vivo platforms — Alfa Cytology supports your hematologic oncology program end to end.
👉 Learn more: https://leukemia.alfacytology.com/

10/13/2026

🧬 More options, better odds: the changing prostate cancer treatment landscape

• As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space.
• © Labiotech UG and Labiotech.eu.

💡 Prostate cancer research is moving fast — Alfa Cytology's prostate cancer models support both small molecule and biologic programs.
👉 Learn more: https://www.alfacytology.com/prostate-cancer

10/10/2026

🧬 STAT+: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis

• In this edition of STAT's Health Tech: The story of a startup taking its algorithm for breast cancer risk prediction directly to patients, and more.

💡 From HER2-targeted to triple-negative breast cancer — Alfa Cytology provides the preclinical models your program needs.
👉 Learn more: https://breast-cancer.alfacytology.com/

09/29/2026

🧬 Revumenib + Chemotherapy in Newly Diagnosed AML With NPM1 Mutation: Phase 3 REVEAL-ND Study

• Joshua Zeidner, MD, raises awareness around an active global, phase 3, double-blind trial evaluating a combination regimen for participants with a specific type of acute myeloid leukemia.

💡 Leukemia drug development needs robust in vitro and in vivo platforms — Alfa Cytology supports your hematologic oncology program end to end.
👉 Learn more: https://leukemia.alfacytology.com/

Address

500-B Wheeler Road
Hauppauge, NY
11788

Opening Hours

Monday	9am - 5am
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+15164410170

Website

https://www.alfacytology.com/

Alerts

Be the first to know and let us send you an email when Alfa Cytology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.